The potential therapeutic effects of adiponectin on sepsis-induced hepatocyte injury have been investigated in recent studies, focusing on its interaction with AMP-activated protein kinase (AMPK) within the mechanistic target of mTOR signaling. The gene discussed is ADIPOQ; the disease is Sepsis.